Buyers are currently exercising patience and discipline to account for uncertainty in the global economy, but experts anticipate that healthcare companies and private equity firms will continue to see future M&A deal opportunities in the healthcare industry, given the availability of capital, competitive pressure imposed by larger players and new market entrants, and ongoing challenges related to reimbursement and regulatory issues. This article summarizes some of the key considerations for private equity firms and other parties to consider in evaluating, negotiating and consummating their M&A healthcare deals.
Read the full article: Considerations for Private Equity Firms and Healthcare Companies in M&A Healthcare Deals //
Source: https://www.lexology.com/library/detail.aspx?g=d8d9c9f8-cfa0-4702-bef4-17c1bfd6820b